These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7520137)

  • 1. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
    Massieu L; Tapia R
    Neuroscience; 1994 Apr; 59(4):931-8. PubMed ID: 7520137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
    Lees GJ; Leong W
    Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures.
    Kristensen BW; Noraberg J; Jakobsen B; Gramsbergen JB; Ebert B; Zimmer J
    Brain Res; 1999 Sep; 841(1-2):143-59. PubMed ID: 10546997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
    Parsons CG; Gruner R; Rozental J
    Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX.
    Lees GJ; Leong W
    Neuroreport; 1994 Oct; 5(16):2153-6. PubMed ID: 7532455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
    Zeman S; Lodge D
    Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
    Foster AC; Gill R; Woodruff GN
    J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
    DeGiorgio LA; DeGiorgio N; Volpe BT
    Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
    Moncada C; Arvin B; Le Peillet E; Meldrum BS
    Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamatergic and GABAergic postsynaptic responses of striatal spiny neurons to intrastriatal and cortical stimulation recorded in slice preparations.
    Kita H
    Neuroscience; 1996 Feb; 70(4):925-40. PubMed ID: 8848174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage.
    Benavides J; Fage D; Carter C; Scatton B
    Brain Res; 1987 Sep; 421(1-2):167-72. PubMed ID: 2891401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glutamate receptor agonists and antagonists on Ca2+ uptake in rat hippocampal slices lesioned by glucose deprivation or by kainate.
    Alici K; Gloveli T; Schmitz D; Heinemann U
    Neuroscience; 1997 Mar; 77(1):97-109. PubMed ID: 9044378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
    Stein E; Cox JA; Seeburg PH; Verdoorn TA
    Mol Pharmacol; 1992 Nov; 42(5):864-71. PubMed ID: 1279377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice.
    Laudrup P; Klitgaard H
    Eur J Pharmacol; 1993 Nov; 250(1):15-22. PubMed ID: 7509749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study.
    Massieu L; Morales-Villagrán A; Tapia R
    J Neurochem; 1995 May; 64(5):2262-72. PubMed ID: 7722511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.
    Sheardown MJ; Nielsen EO; Hansen AJ; Jacobsen P; Honoré T
    Science; 1990 Feb; 247(4942):571-4. PubMed ID: 2154034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
    Gill R
    Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.